Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

2.

[Antineutrophil cytoplasmic antibody(ANCA)].

Yoshida M.

Rinsho Byori. 2003 Jul;51(7):644-8. Review. Japanese.

PMID:
12924248
3.

Scleroderma associated with ANCA-associated vasculitis.

Rho YH, Choi SJ, Lee YH, Ji JD, Song GG.

Rheumatol Int. 2006 Mar;26(5):369-75. Epub 2005 Jul 20. Review.

PMID:
16032390
4.

Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.

Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA.

Arthritis Rheum. 2000 Jan;43(1):226-31. Review.

5.
6.

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group.

Am J Kidney Dis. 2003 Apr;41(4):776-84. Review.

PMID:
12666064
7.
8.

Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature.

Hervier B, Pagnoux C, Agard C, Haroche J, Amoura Z, Guillevin L, Hamidou MA; French Vasculitis Study Group.

Ann Rheum Dis. 2009 Mar;68(3):404-7. doi: 10.1136/ard.2008.096131. Epub 2008 Oct 28. Review.

PMID:
18957485
9.
10.

Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis?

Fussner LA, Specks U.

Curr Opin Rheumatol. 2015 May;27(3):231-40. doi: 10.1097/BOR.0000000000000170. Review.

PMID:
25775187
11.

Antineutrophil cytoplasmic antibodies as markers for systemic autoimmune disease.

Homer RJ.

Clin Chest Med. 1998 Dec;19(4):627-39, viii. Review.

PMID:
9917957
12.

Immunogenetic aspects of ANCA-associated vasculitides. Editorial overview.

Csernok E, Trabandt A, Gross WL.

Exp Clin Immunogenet. 1997;14(3):177-82. Review.

PMID:
9493786
13.

4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.

Yoshida M.

Intern Med. 2002 Jan;41(1):47-9. Review. No abstract available.

14.

Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

Brons RH, Kallenberg CG, Tervaert JW.

Rheum Dis Clin North Am. 2001 Nov;27(4):833-48. Review.

PMID:
11723767
15.

Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis.

Lesavre P, Kyndt X, Vanhille P, Reumaux D, Guillevin L, Noël LH.

Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):246-8. Review. No abstract available.

PMID:
8946593
16.

Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say?

Wiik AS.

Rheum Dis Clin North Am. 2001 Nov;27(4):799-813, vi-vii. Review.

PMID:
11723765
17.

Mechanisms and markers of vascular damage in ANCA-associated vasculitis.

Haubitz M, Dhaygude A, Woywodt A.

Autoimmunity. 2009 Nov;42(7):605-14. Review.

PMID:
19863378
18.

[Diagnostic interpretation of antineutrophil cytoplasm antibodies (ANCA) in vasculitis].

Barbado Hernández FJ, Gómez Cerezo J.

Rev Clin Esp. 2000 Sep;200(9):524-5. Review. Spanish. No abstract available.

PMID:
11111400
19.

Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

Harper L, Savage CO.

Rheum Dis Clin North Am. 2001 Nov;27(4):887-903. Review.

PMID:
11723770
20.

Pathogenesis of ANCA-associated vasculitis.

Cartin-Ceba R, Peikert T, Specks U.

Curr Rheumatol Rep. 2012 Dec;14(6):481-93. doi: 10.1007/s11926-012-0286-y. Review.

PMID:
22927039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk